Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

The incidence of hepatocellular carcinoma (HCC) related to non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. We analyzed 16 surgically resected HCC cases in which the background liver was pathologically diagnosed as NAFLD. Specimens with Brunt classification grade 3 or higher were a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Satoru Hagiwara, Naoshi Nishida, Kazuomi Ueshima, Yasunori Minami, Yoriaki Komeda, Tomoko Aoki, Masahiro Takita, Masahiro Morita, Hirokazu Chishina, Akihiro Yoshida, Hiroshi Ida, Masatoshi Kudo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b208dfd6ee5e4b9ea59f6d6721684d8a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b208dfd6ee5e4b9ea59f6d6721684d8a
record_format dspace
spelling oai:doaj.org-article:b208dfd6ee5e4b9ea59f6d6721684d8a2021-11-25T17:13:22ZAccumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease10.3390/cells101132572073-4409https://doaj.org/article/b208dfd6ee5e4b9ea59f6d6721684d8a2021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3257https://doaj.org/toc/2073-4409The incidence of hepatocellular carcinoma (HCC) related to non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. We analyzed 16 surgically resected HCC cases in which the background liver was pathologically diagnosed as NAFLD. Specimens with Brunt classification grade 3 or higher were assigned as the fibrotic progression group (<i>n</i> = 8), and those with grade 1 or lower were classified as the non-fibrosis progression group (<i>n</i> = 8). Comprehensive mutational and methylome analysis was performed in cancerous and noncancerous tissues. The target gene mutation analysis with deep sequencing revealed that CTNNB1 and TP53 mutation was observed in 37.5% and TERT promoter mutation was detected in 50% of cancerous samples. Furthermore, somatic mutations in non-cancerous samples were less frequent, but were observed regardless of the progression of fibrosis. Similarly, on cluster analysis of methylome data, status for methylation events involving non-cancerous liver was similar regardless of the progression of fibrosis. It was found that, even in cases of non-progressive fibrosis, accumulation of gene mutations and abnormal methylation within non-cancerous areas were observed. Patients with NAFLD require a rigorous liver cancer surveillance due to the high risk of HCC emergence based on the accumulation of genetic and epigenetic abnormalities, even when fibrosis is not advanced.Satoru HagiwaraNaoshi NishidaKazuomi UeshimaYasunori MinamiYoriaki KomedaTomoko AokiMasahiro TakitaMasahiro MoritaHirokazu ChishinaAkihiro YoshidaHiroshi IdaMasatoshi KudoMDPI AGarticlegenomeliver cancermutationnon-alcoholic fatty liver diseasemethylationBiology (General)QH301-705.5ENCells, Vol 10, Iss 3257, p 3257 (2021)
institution DOAJ
collection DOAJ
language EN
topic genome
liver cancer
mutation
non-alcoholic fatty liver disease
methylation
Biology (General)
QH301-705.5
spellingShingle genome
liver cancer
mutation
non-alcoholic fatty liver disease
methylation
Biology (General)
QH301-705.5
Satoru Hagiwara
Naoshi Nishida
Kazuomi Ueshima
Yasunori Minami
Yoriaki Komeda
Tomoko Aoki
Masahiro Takita
Masahiro Morita
Hirokazu Chishina
Akihiro Yoshida
Hiroshi Ida
Masatoshi Kudo
Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
description The incidence of hepatocellular carcinoma (HCC) related to non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. We analyzed 16 surgically resected HCC cases in which the background liver was pathologically diagnosed as NAFLD. Specimens with Brunt classification grade 3 or higher were assigned as the fibrotic progression group (<i>n</i> = 8), and those with grade 1 or lower were classified as the non-fibrosis progression group (<i>n</i> = 8). Comprehensive mutational and methylome analysis was performed in cancerous and noncancerous tissues. The target gene mutation analysis with deep sequencing revealed that CTNNB1 and TP53 mutation was observed in 37.5% and TERT promoter mutation was detected in 50% of cancerous samples. Furthermore, somatic mutations in non-cancerous samples were less frequent, but were observed regardless of the progression of fibrosis. Similarly, on cluster analysis of methylome data, status for methylation events involving non-cancerous liver was similar regardless of the progression of fibrosis. It was found that, even in cases of non-progressive fibrosis, accumulation of gene mutations and abnormal methylation within non-cancerous areas were observed. Patients with NAFLD require a rigorous liver cancer surveillance due to the high risk of HCC emergence based on the accumulation of genetic and epigenetic abnormalities, even when fibrosis is not advanced.
format article
author Satoru Hagiwara
Naoshi Nishida
Kazuomi Ueshima
Yasunori Minami
Yoriaki Komeda
Tomoko Aoki
Masahiro Takita
Masahiro Morita
Hirokazu Chishina
Akihiro Yoshida
Hiroshi Ida
Masatoshi Kudo
author_facet Satoru Hagiwara
Naoshi Nishida
Kazuomi Ueshima
Yasunori Minami
Yoriaki Komeda
Tomoko Aoki
Masahiro Takita
Masahiro Morita
Hirokazu Chishina
Akihiro Yoshida
Hiroshi Ida
Masatoshi Kudo
author_sort Satoru Hagiwara
title Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
title_short Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
title_full Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
title_fullStr Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
title_full_unstemmed Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
title_sort accumulation of genetic and epigenetic alterations in the background liver and emergence of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b208dfd6ee5e4b9ea59f6d6721684d8a
work_keys_str_mv AT satoruhagiwara accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT naoshinishida accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT kazuomiueshima accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT yasunoriminami accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT yoriakikomeda accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT tomokoaoki accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT masahirotakita accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT masahiromorita accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT hirokazuchishina accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT akihiroyoshida accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT hiroshiida accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
AT masatoshikudo accumulationofgeneticandepigeneticalterationsinthebackgroundliverandemergenceofhepatocellularcarcinomainpatientswithnonalcoholicfattyliverdisease
_version_ 1718412612443570176